Affiliation:
1. Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str., 10676, Athens, Greece
Abstract
Cardiovascular magnetic resonance imaging (CMR) allows the early diagnosis of various cardiovascular
pathophysiologic phenomena in autoimmune diseases. Preliminary studies suggest that CMR holds a promising role in
initiating the necessary changes in anti-rheumatic and cardiac treatment among patients with autoimmune diseases and
cardiovascular diseases (CVD). It is widely known that the presence of late gadolinium enhancement (LGE) has been
related to worse cardiovascular prognosis. CMR has been documented to be the most valuable tool for diagnosis and risk
prediction of cardiac involvement in a sarcoidosis population, while in SLE, the gap between clinical and autopsy
diagnosis of myocardial disease could be narrowed with the implementation of CMR. In different connective tissue
diseases, including SLE, LGE has been demonstrated to be present, early after the initial diagnosis of SLE. Considering
that CMR including LGE identifies more patients with silent myocardial disease in SLE and other connective tissue
diseases than echocardiography, CMR should be the preferred imaging modality, especially in the era of modern
techniques with a broader availability and expertise. In this review, we summarize the major indications, advantages and
limitations of the use of CMR among patients with autoimmune disorders.
Publisher
Bentham Science Publishers Ltd.
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献